CARBOPLATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carboplatin, and when can generic versions of Carboplatin launch?
Carboplatin is a drug marketed by Cipla Ltd, Fresenius Kabi Usa, Hikma, Hospira, Natco Pharma Usa, Pliva, Sandoz, Watson Labs Teva, Accord Hlthcare, Actavis Totowa, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Meitheal, Norvium Bioscience, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sun Pharm, Teva Parenteral, Teva Pharms Usa, and Teyro Labs. and is included in thirty-three NDAs.
The generic ingredient in CARBOPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the carboplatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carboplatin
A generic version of CARBOPLATIN was approved as carboplatin by HOSPIRA on October 14th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARBOPLATIN?
- What are the global sales for CARBOPLATIN?
- What is Average Wholesale Price for CARBOPLATIN?
Summary for CARBOPLATIN
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 33 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 2,994 |
| Patent Applications: | 228 |
| Drug Prices: | Drug price information for CARBOPLATIN |
| DailyMed Link: | CARBOPLATIN at DailyMed |
Recent Clinical Trials for CARBOPLATIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| EMD Serono | Phase 1 |
| Istituto Oncologico Veneto IRCCS | Phase 2 |
| Yale University | Phase 1 |
Pharmacology for CARBOPLATIN
| Drug Class | Platinum-based Drug |
Medical Subject Heading (MeSH) Categories for CARBOPLATIN
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPLATIN
US Patents and Regulatory Information for CARBOPLATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 091063-002 | Nov 9, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077139-002 | Sep 21, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 205487-004 | Aug 3, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Totowa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078732-003 | Feb 6, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmachemie Bv | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077269-004 | Dec 28, 2007 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077247-003 | Oct 21, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 076517-001 | Oct 14, 2004 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
